Hopfield Jessica
CIK 0001648715
Director
Filings
19
Latest May 21, 2026
Issuers covered
4
Showing
19 of 19
Page 1
Track record
3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +2.3% | +3.4% | +5.8% | -2.4% |
| 90 days | 3 | 33% | -16.3% | -20.7% | +3.1% | -31.3% |
| 180 days | 3 | 0% | -16.1% | -4.1% | -1.9% | -42.2% |
| 365 days | 3 | 33% | -23.2% | -48.4% | +52.7% | -73.7% |
Issuers
Companies where Hopfield Jessica has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PODD | Insulet Corp | 7 | May 21, 2026 |
| EDIT | Editas Medicine, Inc. | 5 | Jun 10, 2025 |
| CELL | Bruker Cellular Analysis, Inc. | 4 | Oct 3, 2023 |
| MRVI | Maravai Lifesciences Holdings, Inc. | 3 | Jun 18, 2025 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|